Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
11/2013
11/20/2013EP1757595B1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
11/20/2013CN103402977A Ingenol-3-acylates III and ingenol-3-carbamates
11/20/2013CN103402973A Compound and method for producing same, as well as method for producing oseltamivir phosphate
11/20/2013CN103396342A Preparation of modified polyfunctional acrylate photo polymerization monomers based on epoxidized soybean oil
11/20/2013CN102584634B Polyurethane using vinyl ether as end group and synthesis method thereof
11/20/2013CN102134206B Method for preparing rivastigmine
11/20/2013CN101913973B Preparation and use of alkylating agents
11/19/2013CA2603030C Benzyloxypropylamine derivative
11/19/2013CA2558848C Isoxazoline-substituted benzamide compound and pesticide
11/14/2013US20130303531 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
11/13/2013CN102786441B Preparation method of rivastigmine, intermediates and preparation method of intermediates
11/13/2013CN102584631B Urethane polymeric monomer with end groups including vinyl ether and allyl ether and synthetic method thereof
11/13/2013CN102250014B Method for preparing chiral 1-benzyloxycarbonyl hexahydropyridazine-3-carboxylic acid and chiral 1, 2-dibenzyloxycarbonyl hexahydropyridazine-3-carboxylic acid
11/13/2013CN102146048B Lacosamide intermediate compound and preparation method and application thereof
11/12/2013US8580887 High-functionality polyisocyanates containing urethane groups
11/12/2013US8580850 Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use
11/12/2013CA2537093C Compound capable of binding s1p receptor and pharmaceutical use thereof
11/07/2013WO2013165606A1 Modulators of the relaxin receptor 1
11/07/2013WO2013165575A1 Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives
11/07/2013US20130296594 Photocurable compound
11/07/2013US20130296559 Isoxazoline-substituted benzamide compound and pesticide
11/07/2013US20130296551 7-membered ring compound and method of production and pharmaceutical application thereof
11/07/2013US20130296389 Fungicide Active Substance Combinations
11/07/2013US20130296332 1h-quinazoline-2,4-diones
11/06/2013CN102020589B Tert-butyl carbamate derivative and preparation method and application thereof
11/06/2013CN101939290B Process for production of radioactive-fluorine-labeled organic compound
11/05/2013CA2491994C Modulators of the glucocorticoid receptor
10/2013
10/31/2013US20130287686 Fluorinated 2-Amino-4-(Benzylamino)Phenylcarbamate Derivatives
10/30/2013EP2657222A1 Beta-aminocarbonyl compound production method
10/30/2013EP2655349A1 Methods of making diastereomeric organic compounds
10/30/2013EP2655323A1 Ingenol-3-acylates iii and ingenol-3-carbamates
10/30/2013EP2655321A1 Purification of precursor compound by crystallisation
10/30/2013CN103373941A Preparation method of retigabine and intermediate thereof
10/30/2013CN103373940A Novel process for synthesizing N-FMOC-amino acid crude product of non-active side chain
10/30/2013CN102757365B Method for preparing peramivir key intermediate
10/29/2013CA2621640C Optically active diamine derivative and process for producing the same
10/24/2013US20130281453 Anti-cancer serine hydrolase inhibitory carbamates
10/24/2013US20130280305 Cationic lipid
10/23/2013CN103360860A AIP (Aluminum Isopropoxide) type nonionic surfactant as well as preparation method and application thereof
10/23/2013CN103360591A Fluorine-containing ether monomer, contact lens material and contact lens
10/23/2013CN103360348A Carfilzomib intermediate and preparation method thereof, and preparation method of Carfilzomib
10/17/2013US20130274503 Process for the manufacture of bridged monobactam intermediates
10/17/2013US20130274502 Processes For Preparing A Polymeric Compound
10/17/2013US20130274463 Process and intermediates for preparing macrolactams
10/16/2013EP2650279A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
10/16/2013EP2648714A2 Lysophosphatidic acid receptor antagonists and uses thereof
10/16/2013CN102665712B Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphtalenyl) ester
10/16/2013CN101952249B Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
10/15/2013US8557388 Erosion resistant coatings for leading edges of airfoils
10/09/2013EP2646411A1 Preparation of pet precursor
10/09/2013CN103347510A Lysophosphatidic acid receptor antagonists and uses thereof
10/09/2013CN103342656A Synthesis method of Telaprevir intermediate
10/09/2013CN103342648A Method for preparing retigabine intermediate and method for preparing retigabine
10/08/2013US8554373 Preparation and use of alkylating agents
10/08/2013US8552054 Anticancer agents, viricides, psychological disorders
10/08/2013US8551445 Preparation and use of alkylating agents
10/08/2013CA2721222C Fungicidal active compound combinations
10/03/2013WO2013057439A3 Stable, ready-to-use liquid polyurethane resin composition and uses thereof
10/03/2013WO2013057429A3 Polymerisable plasticiser, liquid polyurethane resin composition comprising same and uses thereof
10/03/2013US20130261316 Neprilysin inhibitors
10/03/2013US20130261178 Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases
10/03/2013US20130261133 Therapeutic Compounds for Protozoal and Microbial Infections and Cancer
10/02/2013EP2644618A1 tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators
10/02/2013CN103333091A Anticoagulation diamine derivative
10/02/2013CN103333090A Preparation method of BOC-L-phenylalanine
10/02/2013CN103333089A Crystal form of N-[(2S, 3R)-4-phenyl-3-benzyl-3-formylaminobenzoxy-2-hydroxybutyryl]-L-benzyl leucine and preparation method thereof
10/02/2013CN103333088A Nalpha-fluorenylmethyloxycarbonyl-Nepsilon-trifluoroacetyl-lysine preparation method
10/02/2013CN103333087A Nalpha-fluorenylmethyloxycarbonyl-Nepsilon- fluorenylmethyloxycarbonyl-lysine preparation method
10/02/2013CN102336687B Method for catalytically synthesizing carbamic acid hydroxyalkyl ester
10/02/2013CN101534861B Polyalkylene oxides having hindered ester-based biodegradable linkers
09/2013
09/26/2013US20130253004 Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
09/25/2013EP2641897A2 A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
09/25/2013CN103328437A Addition-fragmentation agents
09/25/2013CN103319374A Asymmetric synthetic method of (S)-rivastigmine
09/25/2013CN103319373A Preparation method and related intermediates of 1-[2-amino-1-(4-benzyloxyphenyl)-ethyl]-cyclohexanol
09/25/2013CN102504250B Ammonia ester bond small molecular weight polyethyleneimine (PEI) cross-linked derivatives, and preparation method, application and composition thereof
09/25/2013CN101611857B New menthyl derivatives as flavor substances
09/24/2013US8541628 cytofectins; delivering an anionic molecule into a cell by complexing with cationic lipids of invention
09/19/2013WO2013135360A1 Aminoacid lipids
09/18/2013EP2638009A2 Fluorinated hdac inhibitors and uses thereof
09/18/2013CN103304534A Preparation method of rosinyl cyclic carbonate and quaternary ammonium salt antibacterial derivative thereof
09/18/2013CN103304447A Synthesis process of (S)-rivastigmine
09/18/2013CN103304446A Derivatization method of optically active phenylacetylene compound
09/18/2013CN103304445A Cation polyglycerol ester lipid and synthetic method and application thereof
09/18/2013CN102311365B Synthetic process for ethyl 4-trifluoromethoxy-anilino-formate
09/18/2013CN102153481B Application of thionyl chloride and alcohol as selective deacylation reagents for N-aryl fatty amide or N-heterocyclic fatty amide
09/17/2013US8536229 Acetylene derivatives having MGluR 5 antagonistic activity
09/12/2013US20130237573 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS
09/12/2013US20130236434 Agonists that enhance binding of integrin-expressing cells to integrin receptors
09/11/2013EP2636667A1 Benzamide derivative with anticancer activity and preparation method and use thereof
09/11/2013CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases
09/11/2013CN103288761A New method for synthesizing 1,2,3,4-quinazoline-2,4-diketone derivative
09/11/2013CN103288682A Simple and convenient method for purification of (4-aminophenyl) carbamic tert-butyl ester
09/11/2013CN102127003B Intermediate compound of anti-flu medicine Tamiflu and synthesis method and applications thereof
09/06/2013WO2013130849A1 Substituted dioxopiperidinyl phthalimide derivatives
09/05/2013US20130231386 Synthesis, methods of using, and compositions of cycloalkylmethylamines
09/05/2013US20130230501 Cycloalkyl-Substituted Imidazole Derivative
09/04/2013EP2632912A2 Anti-cancer serine hydrolase inhibitory carbamates
09/04/2013CN103282346A Process for preparation of phenyl carbamate derivatives
09/04/2013CN103275249A Free radical photoinitiator containing single vinyl ether group or single propenyl ether group, and preparation method thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 157